Cigna Group
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
CI$303.13+2.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income
| The Cigna GroupConsolidated Statements of Income | ||||
|---|---|---|---|---|
| Unaudited · Unaudited | ||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
| (In millions, except per share amounts) | 2024 | 2023 | 2024 | 2023 |
| Revenues | ||||
| Pharmacy revenues | $48,284 | $34,531 | $135,421 | $100,639 |
| Premiums | 11,436 | 10,998 | 34,493 | 33,062 |
| Fees and other revenues | 3,889 | 3,198 | 10,862 | 9,574 |
| Net investment income | 85 | 321 | 696 | 876 |
| TOTAL REVENUES | 63,694 | 49,048 | 181,472 | 144,151 |
| Benefits and expenses | ||||
| Pharmacy and other service costs | 47,565 | 33,639 | 133,488 | 98,540 |
| Medical costs and other benefit expenses | 9,527 | 8,927 | 28,482 | 27,007 |
| Selling, general and administrative expenses | 3,590 | 3,788 | 10,979 | 10,760 |
| Amortization of acquired intangible assets | 436 | 454 | 1,279 | 1,368 |
| TOTAL BENEFITS AND EXPENSES | 61,118 | 46,808 | 174,228 | 137,675 |
| Income from operations | 2,576 | 2,240 | 7,244 | 6,476 |
| Interest expense and other | (376) | (365) | (1,073) | (1,086) |
| Loss on sale of businesses | (87) | (21) | (106) | (21) |
| Net realized investment losses | (921) | (14) | (2,805) | (44) |
| Income before income taxes | 1,192 | 1,840 | 3,260 | 5,325 |
| TOTAL INCOME TAXES | 367 | 391 | 1,018 | 1,060 |
| Net income | 825 | 1,449 | 2,242 | 4,265 |
| Less: Net income attributable to noncontrolling interests | 86 | 41 | 232 | 130 |
| SHAREHOLDERS’ NET INCOME | $739 | $1,408 | $2,010 | $4,135 |
| Shareholders' net income per share | ||||
| Basic | $2.65 | $4.79 | $7.13 | $14.03 |
| Diluted | $2.63 | $4.74 | $7.05 | $13.89 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.